Loading clinical trials...
Loading clinical trials...
Pilot Study for Treatment of Meibomian Gland Dysfunction (MGD) Prior to Cataract Surgery
Conditions
Interventions
LipiFlow Pre-Treatment
LipiFlow Post-treatment
Locations
7
United States
Chicago Cornea Consultants, Ltd.
Hoffman Estates, Illinois, United States
Jackson Eye
Lake Villa, Illinois, United States
Charles River Eye Associates
Winchester, Massachusetts, United States
Associated Eye Care
Stillwater, Minnesota, United States
Ophthalmology Consultants, Ltd.
St Louis, Missouri, United States
The May Eye Care Center
Hanover, Pennsylvania, United States
Start Date
March 1, 2013
Primary Completion Date
January 1, 2015
Completion Date
January 1, 2015
Last Updated
September 4, 2018
NCT07295691
NCT03135327
NCT06771427
NCT06220474
NCT06291194
NCT04603222
Lead Sponsor
TearScience, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions